According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2022 the company made a revenue of $0.17 B a decrease over the years 2021 revenue that were of $0.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.13 B | -24.06% |
2022 | $0.17 B | -37.61% |
2021 | $0.27 B | 48.66% |
2020 | $0.18 B | 54.98% |
2019 | $0.12 B | -52.17% |
2018 | $0.25 B | 78.21% |
2017 | $0.14 B | 29.48% |
2016 | $0.10 B | 51.54% |
2015 | $71.91 M | 11.43% |
2014 | $64.53 M | 31.79% |
2013 | $48.97 M | 56.02% |
2012 | $31.38 M | 4.5% |
2011 | $30.03 M | 27.61% |
2010 | $23.53 M | -39.56% |
2009 | $38.94 M | 42.57% |
2008 | $27.31 M | 111.84% |
2007 | $12.89 M | -82.77% |
2006 | $74.81 M | -54.34% |
2005 | $0.16 B | 3.34% |
2004 | $0.15 B | 12.35% |
2003 | $0.14 B | 46.05% |
2002 | $96.64 M | 26.59% |
2001 | $76.34 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 70,739.36% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 44,447.42% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 25,886.64% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 21,367.63% | ๐บ๐ธ USA |
Baxter BAX | $14.94 B | 11,284.16% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 45,678.82% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.00 B | 34,173.57% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 28,723.31% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | $25.72 M | -80.41% | ๐บ๐ธ USA |